DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
138 hedge funds and large institutions have $227M invested in DIPLOMAT PHARMACY, INC. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 34 closing their positions.
379% more call options, than puts
Call options by funds: $2.56M | Put options by funds: $536K
3% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 34
2% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 43
1% more funds holding
Funds holding: 137 → 138 (+1)
28% less capital invested
Capital invested by funds: $317M → $227M (-$90M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$11M |
| 2 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$10.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.02M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$6.34M |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$5.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$26.5M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$17.1M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$16.2M |
| 4 |
DM
Deerfield Management
New York
|
-$14.7M |
| 5 |
JP Morgan Chase
New York
|
-$5.3M |
DPLO Hedge Fund Activity: Q4 2019 in Review
138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2019, worth a combined $227M — down 28% from $317M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new DPLO positions and 34 closed out — a net gain of 1 holder — while 44 added to existing stakes and 43 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $11M. The largest seller was Armistice Capital, exiting entirely with an estimated $26.5M sold.
- 138 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2019, up from 137 in Q3 2019.
- Funds reported $227M of DIPLOMAT PHARMACY, INC. stock for Q4 2019, down 28% quarter-over-quarter.
- 35 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2019 and 34 closed out, a net change of +1 holder.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2019 was Renaissance Technologies, an estimated $11M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q4 2019 was Armistice Capital, an estimated $26.5M sold.
Based on aggregated 13F filings for Q4 2019.